All In MedTech

Device Trial Radar · NCT07808554

CSP-SOLIA-REGISTRY

Brazilian Assessment of Technique, Utilization, QRS Response, and Long-term Electrical Performance of the Solia CSP Lead

Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Nov 2, 2026

Primary completion

Mar 2, 2028

Study completion Sep 2, 2029

Sponsor

Lead sponsor
Hospital SOS CardioResearch network
Sponsor type
Research network
First posted
Sep 9, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The CSP Registry is a prospective, multicenter, observational, real-world study designed to evaluate the acute feasibility and long-term performance of the Solia CSP lead in Brazilian patients with a clinical indication for permanent ventricular pacing. Approximately 300 adult participants will be enrolled at up to 10 electrophysiology centers in Brazil and followed for up to 24 months. The study will assess implantation success, electrical performance, maintenance of conduction system capture, procedure- and device-related complications, and relevant clinical outcomes.

Conditions

  • Left Bundle Branch Area Pacing

Interventions

  • Solia CSP S LeadDevice

    The Solia CSP S lead (BIOTRONIK) is a stylet-driven, fixed-helix pacing lead used for conduction system pacing (CSP), preferably left bundle branch area pacing (LBBAP). The decision to use the lead is made by the treating physician according to clinical indication and routine practice, prior to and independently of study enrollment. The device is used within its approved indication and instructions for use. The study does not assign the intervention or modify the implantation procedure, but prospectively evaluates the lead's acute feasibility, electrical performance, safety, and clinical outcomes during follow-up.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Solia CSP Lead Success at 12 MonthsTime frame: 12 months
  2. Solia CSP Lead Success at 12 MonthsTime frame: From implantation through 12 months

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.